Meiji Yasuda Asset Management CO Ltd. Exelixis, Inc. Transaction History
Meiji Yasuda Asset Management CO Ltd.
- $2.56 Billion
- Q4 2024
A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Exelixis, Inc. stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 7,019 shares of EXEL stock, worth $230,293. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,019Holding current value
$230,293% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
550Shares Held
245MCall Options Held
2.88MPut Options Held
2.3M-
Black Rock Inc. New York, NY33.5MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$966 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$834 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$504 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$375 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...